mitomycin has been researched along with Malignant Mesothelioma in 7 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with PC from colorectal or appendiceal cancer, pseudomyxoma peritonei or malignant peritoneal mesothelioma referred to the single national HIPEC centre were prospectively registered from June 2006 to July 2012." | 1.39 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience. ( Hagemann-Madsen, R; Iversen, LH; Laurberg, S; Rasmussen, PC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, C | 1 |
| Buchholz, M | 1 |
| Majchrzak-Stiller, B | 1 |
| Peters, I | 1 |
| Fein, D | 1 |
| Müller, T | 1 |
| Uhl, W | 1 |
| Höhn, P | 1 |
| Strotmann, J | 1 |
| Braumann, C | 1 |
| Forsythe, SD | 1 |
| Erali, RA | 1 |
| Edenhoffer, N | 1 |
| Meeker, W | 1 |
| Wajih, N | 1 |
| Schaaf, CR | 1 |
| Laney, P | 1 |
| Vanezuela, CD | 1 |
| Li, W | 1 |
| Levine, EA | 1 |
| Soker, S | 1 |
| Votanopoulos, KI | 1 |
| Malgras, B | 1 |
| Gayat, E | 1 |
| Aoun, O | 1 |
| Lo Dico, R | 1 |
| Eveno, C | 1 |
| Pautrat, K | 1 |
| Delhorme, JB | 1 |
| Passot, G | 1 |
| Marchal, F | 1 |
| Sgarbura, O | 1 |
| Ferron, G | 1 |
| Goéré, D | 1 |
| Andre, T | 1 |
| Pocard, M | 1 |
| Iversen, LH | 1 |
| Rasmussen, PC | 1 |
| Hagemann-Madsen, R | 1 |
| Laurberg, S | 1 |
| Magge, D | 1 |
| Zenati, MS | 1 |
| Austin, F | 1 |
| Mavanur, A | 1 |
| Sathaiah, M | 1 |
| Ramalingam, L | 1 |
| Jones, H | 1 |
| Zureikat, AH | 1 |
| Holtzman, M | 1 |
| Ahrendt, S | 1 |
| Pingpank, J | 1 |
| Zeh, HJ | 1 |
| Bartlett, DL | 1 |
| Choudry, HA | 1 |
| Shetty, SJ | 1 |
| Bathla, L | 1 |
| Govindarajan, V | 1 |
| Thomas, P | 1 |
| Loggie, BW | 1 |
| Huang, Y | 1 |
| Alzahrani, NA | 1 |
| Liauw, W | 1 |
| Morris, DL | 1 |
7 other studies available for mitomycin and Malignant Mesothelioma
| Article | Year |
|---|---|
Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma-A 3-D In Vitro Study.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; | 2022 |
Cisplatin exhibits superiority over MMC as a perfusion agent in a peritoneal mesothelioma patient specific organoid HIPEC platform.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; Hypert | 2023 |
Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 2018 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Carcinoma; Colorectal Neoplasms; Co | 2013 |
Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 2014 |
Comparison of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with mitomycin or carboplatin for diffuse malignant peritoneal mesothelioma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Female; | 2014 |
Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent diffuse malignant peritoneal mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Cisplatin; Cohort Studies; C | 2015 |